International drug companies had halted research in the country due to sanctions Pharmaceutical companies in Russia have increased clinical trials as foreign drug firms have halted such activity in the country due to sanctions, business daily Vedomosti reported on Tuesday, citing the Russian register of approvals for clinical trials. The data demonstrates that the number of clinical trials has significantly increased since last year. Russian pharmaceutical multinational R-Pharm has reportedly obtained 22 approvals for clinical studies since the beginning of the current year, compared to only seven permits receive
Hence then, the article about russian pharma industry boosts number of clinical trials vedomosti was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Russian pharma industry boosts number of clinical trials – Vedomosti )